Stocks · Health care · Pharmaceutical Preparations

Nurix Therapeutics, Inc.

NRIX Clue Score49
United States Fiscal year ends November CIK 0001549595 Results filed 13 Oct 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
Houte Hans van
4 Nov 2026
Chief Financial Officer
Sold on a plan
1,469
$16.20
$23.80K
Houte Hans van
4 Nov 2026
Chief Financial Officer
Sold on a plan
3,300
$15.38
$50.76K
Christine Ring
3 Nov 2026
Chief Legal Officer
Sold on a plan
6,113
$25.83
$157.92K

What was left out

Form 4 filings counted 7
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 8
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 61,819
History held since 29 Jul 2020